KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

Claude just got a skill upgrade and it’s coming for your workflows

Anthropic’s new ‘Skills’ feature lets Claude autonomously perform structured tasks, another sign that AI agents are moving ...